Literature DB >> 9533658

A panel set for epitope analysis of myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody MPO-ANCA using recombinant hexamer histidine-tagged MPO deletion mutants.

K Tomizawa1, E Mine, A Fujii, Y Y Ohashi, S Yamagoe, Y Hashimoto, A Ishida-Okawara, M Ito, M Tanokura, T Yamamoto, Y Arimura, T Nagasawa, S Mizuno, K Suzuki.   

Abstract

A major target protein of antineutrophil cytoplasmic antibody with a perinuclear staining pattern (P-ANCA) has been identified as myeloperoxidase (MPO). Recombinant deletion mutants of MPO, eight fragments of the heavy-chain subunit, and two fragments of the light chain subunit were expressed in E. coli using a pQE expression vector. The recombinant hexamer histidine-tagged fragments were partially purified as the denatured proteins on a Ni2+-charged nitrirotriacetic acid column. The recombinant fragments were reacted with a rabbit polyclonal antibody to human MPO in Western blotting. In addition, the reactivities of the proteins with MPO-ANCA-positive sera of four patients with renal diseases were examined by Western blotting. The profile of the reactivity showed that different sera recognized different sets of fragments of the heavy chain, whereas no serum reacted with the fragments of the light chain. These results indicate that the sera of patients with MPO-ANCA-positive diseases showed varied reactivities with the different fragments. Furthermore, an ELISA system using a set of the fragments completely purified by Sephacryl S-200HR column chromatography was established. The panel set is useful for subclassification of MPO-ANCA-related diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9533658     DOI: 10.1023/a:1023251001261

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  24 in total

1.  Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3.

Authors:  P Bini; J E Gabay; A Teitel; M Melchior; J L Zhou; K B Elkon
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

2.  Anti-native and recombinant myeloperoxidase monoclonals and human autoantibodies.

Authors:  M A Audrain; T A Baranger; N Moguilevski; S J Martin; A Devys; C M Lockwood; J Y Muller; V L Esnault
Journal:  Clin Exp Immunol       Date:  1997-01       Impact factor: 4.330

3.  Structure and membrane topology of the high-affinity receptor for human IFN-gamma: requirements for binding IFN-gamma. One single 90-kilodalton IFN-gamma receptor can lead to multiple cross-linked products and isolated proteins.

Authors:  M Fountoulakis; M Kania; L Ozmen; H R Loetscher; G Garotta; A P van Loon
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Multiple species of myeloperoxidase messenger RNAs produced by alternative splicing and differential polyadenylation.

Authors:  K Hashinaka; C Nishio; S J Hur; F Sakiyama; S Tsunasawa; M Yamada
Journal:  Biochemistry       Date:  1988-08-09       Impact factor: 3.162

6.  Association of autoantibodies to myeloperoxidase with different forms of vasculitis.

Authors:  J W Tervaert; R Goldschmeding; J D Elema; P C Limburg; M van der Giessen; M G Huitema; M I Koolen; R J Hené; T H The; G K van der Hem
Journal:  Arthritis Rheum       Date:  1990-08

7.  Antineutrophil cytoplasmic autoantibodies (ANCA) recognizing a recombinant myeloperoxidase subunit.

Authors:  E Pedrollo; L Bleil; F A Bautz; J R Kalden; E K Bautz
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

8.  Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis.

Authors:  I E Coremans; E C Hagen; M R Daha; F J van der Woude; E A van der Voort; C Kleijburg-van der Keur; F C Breedveld
Journal:  Arthritis Rheum       Date:  1992-12

9.  Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose.

Authors:  D C Kaslow; J Shiloach
Journal:  Biotechnology (N Y)       Date:  1994-05

10.  New metal chelate adsorbent selective for proteins and peptides containing neighbouring histidine residues.

Authors:  E Hochuli; H Döbeli; A Schacher
Journal:  J Chromatogr       Date:  1987-12-18
View more
  14 in total

1.  Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases.

Authors:  H Chikazawa; K Nishiya; A Matsumori; K Hashimoto
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

Review 2.  Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune disease.

Authors:  William F Pendergraft; Barrak M Pressler; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  J Mol Med (Berl)       Date:  2004-12-11       Impact factor: 4.599

3.  AP-VAS 2012 case report: an atypical case of microscopic polyangiitis presenting with acute tubulointerstitial nephritis without glomerular change.

Authors:  Hideki Kasahara; Nakamura Hiroyuki; Masahide Shinohara; Takao Koike
Journal:  CEN Case Rep       Date:  2013-12-27

Review 4.  Neutrophil functions of patients with vasculitis related to myeloperoxidase-specific anti-neutrophil antibody.

Authors:  K Suzuki
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

5.  Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis.

Authors:  Aleeza J Roth; Joshua D Ooi; Jacob J Hess; Mirjan M van Timmeren; Elisabeth A Berg; Caroline E Poulton; JulieAnne McGregor; Madelyn Burkart; Susan L Hogan; Yichun Hu; Witold Winnik; Patrick H Nachman; Coen A Stegeman; John Niles; Peter Heeringa; A Richard Kitching; Stephen Holdsworth; J Charles Jennette; Gloria A Preston; Ronald J Falk
Journal:  J Clin Invest       Date:  2013-03-15       Impact factor: 14.808

6.  Epitope specificity of myeloperoxidase antibodies: identification of candidate human immunodominant epitopes.

Authors:  B F Bruner; E S Vista; D M Wynn; J A James
Journal:  Clin Exp Immunol       Date:  2011-03-14       Impact factor: 4.330

7.  Contribution of myeloperoxidase to coronary artery vasculitis associated with MPO-ANCA production.

Authors:  A Ishida-Okawara; T Oharaseki; K Takahashi; Y Hashimoto; Y Aratani; H Koyama; N Maeda; S Naoe; K Suzuki
Journal:  Inflammation       Date:  2001-12       Impact factor: 4.092

Review 8.  B cell epitope specificity in ANCA-associated vasculitis: does it matter?

Authors:  Y M van der Geld; C A Stegeman; C G M Kallenberg
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

9.  Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule.

Authors:  H Ye; M-H Zhao; Y Gao; X-H Guo; H-Y Wang
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

10.  Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis.

Authors:  Meghan E Free; Katherine G Stember; Jacob J Hess; Elizabeth A McInnis; Olivier Lardinois; Susan L Hogan; Yichun Hu; Carmen Mendoza; Andrew K Le; Alex J Guseman; Mark A Pilkinton; Dante S Bortone; Kristen Cowens; John Sidney; Edita Karosiene; Bjoern Peters; Eddie James; William W Kwok; Benjamin G Vincent; Simon A Mallal; J Charles Jennette; Dominic J Ciavatta; Ronald J Falk
Journal:  J Autoimmun       Date:  2019-08-02       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.